search

Active clinical trials for "Genital Neoplasms, Female"

Results 31-40 of 133

Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic...

Malignant Peritoneal NeoplasmMalignant Retroperitoneal Neoplasm32 more

This phase Ib trial studies the side effects and best dose of nivolumab with or without ipilimumab in treating patients with female reproductive cancer that has come back (recurrent) or is high grade and has spread extensively throughout the peritoneal cavity (metastatic). Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

Active30 enrollment criteria

Selumetinib and Olaparib in Solid Tumors

Malignant Neoplasm of BreastMalignant Neoplasms of Digestive Organs3 more

This study has 2 phases: Phase 1 (dose escalation) and Phase 2 (dose expansion). The goal of Phase 1 of this clinical research study is to find the highest tolerable dose combination of selumetinib and olaparib that can be given to patients who have solid tumors that are advanced or recurrent (has returned after treatment). The goal of Phase 2 is to learn if the highest tolerable dose combination found in Phase 1 can help to control advanced or recurrent solid tumors. The safety of the study drug combination will also be studied in both parts. This is an investigational study. Selumetinib is not FDA approved or commercially available. It is currently being used for research purposes only. Olaparib is FDA approved and commercially available for the treatment of ovarian cancer that has a certain type of genetic mutation (change). It is considered investigational to use selumetinib in combination with olaparib to treat advanced or recurrent cancer. The study doctor can explain how the study drugs are designed to work. Up to 90 participants will be enrolled in this study. All will take part at MD Anderson.

Active42 enrollment criteria

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological...

Cervical AdenocarcinomaCervical Adenosarcoma46 more

This phase I trial studies the side effects and best dose of nab-paclitaxel and bevacizumab in treating patients with stage IV melanoma that cannot be removed by surgery (unresectable), cancer of the cervix, endometrium, ovary, fallopian tube or peritoneal cavity. Drugs used in chemotherapy, such as nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may stop or slow tumor growth by blocking the growth of new blood vessels necessary for tumor growth. Giving nab paclitaxel and bevacizumab may kill more tumor cells than nab-paclitaxel alone.

Active82 enrollment criteria

Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic

Malignant Female Reproductive System Neoplasm

This study compares different screening approaches to detect abnormal cell growth on the cervix that could be an early sign of cervical cancer. The lesions are caused by an infection of human papillomavirus, also called HPV. Using new methods to detect HPV may help doctors find ways to improve cervical cancer screening for women living with human immunodeficiency virus (HIV) in the Dominican Republic and in other countries.

Recruiting9 enrollment criteria

Contrast-Enhanced Ultrasound Imaging Scan for the Detection of Sentinel Lymph Nodes in Patients...

Cervical CarcinomaMalignant Female Reproductive System Neoplasm2 more

This clinical trial compares the use of ultrasound for the detection of sentinel lymph nodes (SLNs) to the standard of care (which varies depending on cancer treatment). The ultrasound contrast agent is called Sonazoid and it consists of tiny gas-filled bubbles about the side of red blood cells. Diagnostic procedures, such as ultrasound with Sonazoid, may help identify more SLNs than standard of care in patients with cervical, vaginal, or vulvar cancer.

Recruiting15 enrollment criteria

Cancer Genetic Testing in Ethnic Populations

Breast CarcinomaCarcinoma of Unknown Primary9 more

This clinical trial examines the integration of cancer genetic testing in various ethnic populations. Studying individuals and families at risk of cancer may help identify cancer genes and other persons at risk. The information from this study may provide an opportunity for cancer risk stratification and individualized screening in these ethnic populations.

Recruiting8 enrollment criteria

Retrospective Study of Brachytherapy

BrachytherapyUterine Cervical Neoplasms5 more

Brachytherapy for gynecological cancers will be studied retrospectively.

Recruiting4 enrollment criteria

Characterization of the Intestinal and Vaginal Microbiota in Long-term Survivors of Gynecological...

Genital NeoplasmsFemale

The study proposes the characterization of the intestinal and vaginal microbiota in long-term radiated cervical and endometrial cancer survivors to study the association with long-term radiotherapy side effects.

Recruiting19 enrollment criteria

Home-Based Telemonitoring Program for Functional Recovery and Symptoms in Gastrointestinal, Genitourinary,...

Digestive System CarcinomaGenitourinary System Carcinoma2 more

This phase III trial compares a home-based telemonitoring program that collects symptom and daily step information to surgeon only care in improving recovery and stopping complications within 30 days after surgery in patients with gastrointestinal, genitourinary, or gynecologic cancer who are scheduled to undergo abdominal surgery. Patients may experience a decrease in functional capacity and experience symptoms like pain and fatigue after surgery, and this may change their ability to walk and function. Home-based telemonitoring of patient symptoms and their ability to walk and function after surgery may help doctors and nurses find and treat problems early, which may improve the patient's recovery and lower the number of complications after surgery.

Recruiting6 enrollment criteria

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Head and Neck CancerHead and Neck Tumor5 more

The purpose of this study is to find out whether the Integrative Medicine at Home (IM@Home) program can help reduce patients' symptoms (such as tiredness, pain, or insomnia) and improve their satisfaction with treatment for their disease. The IM@Home program offers virtual (online rather than in-person) group classes focusing on mind-body practice. Mind-body practice is a health practice that combines mental focus, controlled breathing, and body movements to help relax the body and mind.

Recruiting10 enrollment criteria
1...345...14

Need Help? Contact our team!


We'll reach out to this number within 24 hrs